Ionis Pharmaceuticals, Inc. (IONS) Financials
IONS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 3.0 billion | 2.6 billion |
| March 31, 2026 | 3.4 billion | 3.0 billion |
| Dec. 31, 2025 | 3.5 billion | 3.0 billion |
| Sept. 30, 2025 | 3.0 billion | 2.4 billion |
IONS Free Cash Flow and Stock based compensation
No data available :(
IONS Net Income
No data available :(
IONS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.1 billion | 1.9 billion | 262.5 million |
| March 31, 2026 | 1.9 billion | 1.3 billion | 259.2 million |
| Dec. 31, 2025 | 2.7 billion | 1.9 billion | 262.4 million |
| Sept. 30, 2025 | 2.2 billion | 595.9 million | 262.7 million |
IONS Shares Outstanding
IONS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 16.1 million | 217.1 million | 150.4 million | - |
| March 31, 2026 | 21.8 million | 210.2 million | 150.4 million | - |
| Dec. 31, 2025 | 21.3 million | 280.0 million | 130.0 million | - |
| Sept. 30, 2025 | 3.3 million | 217.8 million | 96.8 million | - |
IONS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 267.9 million | 2.7 million |
| March 31, 2026 | 246.1 million | 3.0 million |
| Dec. 31, 2025 | 203.0 million | 8.0 million |
| Sept. 30, 2025 | 156.7 million | 2.3 million |
IONS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
IONS
Price: $42.38
52 week price:
Earnings Per Share: -3.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: 9.5 millionMarket Capitalization: 7.2 billion